Literature DB >> 23093695

How to use Helicobacter pylori testing in paediatric practice.

Eileen Crowley1, Billy Bourke, Séamus Hussey.   

Abstract

The current reference standard for investigating H. pylori associated disease in children remains upper intestinal endoscopy and biopsies for histology and culture or RUT. Non-invasive tests should be used to confirm H. pylori eradication following treatment. Currently there is insufficient evidence to recommend them over invasive tests in symptomatic children, because they cannot be used reliably in children to diagnose or distinguish H. pylori-associated diseases from conditions that are not H. pylori related. Recent evidence-based guidelines recommend treatment in children with confirmed H. pylori–related diseases. However, with further knowledge of the measurable health risks for H. pylori–infected children, or with the availability of vaccination or future treatment options, the risk-benefit relationship and recommendations regarding non-invasive testing may change.

Entities:  

Mesh:

Year:  2012        PMID: 23093695     DOI: 10.1136/archdischild-2012-301642

Source DB:  PubMed          Journal:  Arch Dis Child Educ Pract Ed        ISSN: 1743-0585            Impact factor:   1.309


  3 in total

1.  Prevalence of Helicobacter pylori and parasites in symptomatic children examined for Helicobacter pylori antibodies, antigens, and parasites in Yemen.

Authors:  Mahmood D Al-Mendalawi
Journal:  Saudi Med J       Date:  2015-01       Impact factor: 1.484

2.  Increased Antibiotic Resistance in Children with Helicobacter pylori Infection: A Retrospective Study.

Authors:  Luca Helmbold; Beniam Ghebremedhin; Aliyah Bellm; Marc A Hopkins; Stefan Wirth; Malik Aydin
Journal:  Pathogens       Date:  2022-01-27

3.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.